Skip to main content
TipRanks
Go Ultimate75% OFF

XTL Biopharmaceuticals Sponsored ADR (HHB0) Q3 2022 Earnings Report

0 Followers

DE:HHB0 Q3 2022 EPS Results

Actual EPS
-EUR 0.13
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
-EUR 0.13

DE:HHB0 Q3 2022 Revenue Results

Actual Revenue
EUR 0
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q3 2022
Date
12/06/2022
Time
TBA
Conference Call
Tuesday, December 6, 2022

Q3 2022 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q3 2022 Earnings Slide Deck

No slide deck is available for this earnings event.

Q3 2022 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:HHB0 Earnings History

DE:HHB0 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Dec 05, 20232023 (Q3)―-0.03-0.1374.17% (+0.10)
May 31, 20232023 (Q1)―-0.150.08-281.72% (-0.23)
Dec 06, 20222022 (Q3)―-0.13-0.130.00% (+0.00)
Nov 24, 20212021 (Q3)―-0.13-0.1-31.30% (-0.03)
May 19, 20212021 (Q1)―0.050980.00% (+0.04)
Jul 24, 20182018 (Q2)―0.01-0.26102.33% (+0.27)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed